BIO-key International (NASDAQ:BKYI) & HP (HPQ) | Critical Contrast


BIO-key International and HP are technology and computer companies, but there is always a lingering question as to which is the superior one? Let us compare the two businesses according to their ownership, earnings, valuation, dividends, profitability, and risk.

BIO-key International, Inc. develops and markets fingerprints biometric identification and related identity-related management. It has a gross revenue of $6.30 million and the price/sales ratio is 1.66. Its net income is -$4.27 million, while the earnings per share and price/earnings ratio is not available in the record. Talking about HP, it provides technologies, products, software, solutions, etc., to consumers, small businesses, and large enterprises. Its gross revenue is $58.47 million and the price is 0.54. The net income of HP is $5.33 billion. The earnings/share and price/earnings ratio are $2.02 and 10.13 respectively. This data tells that HP has higher revenue and earnings than BIO-key International.

Institutional investors own 1.1% and 80.2% shares of BIO-key International and HP respectively. Strong institutional ownership is a sign that hedge fund, huge money managers, and endowments believe a firm will outshine the market over the long term. BIO-key International currently has a consensus price target of $4.00, pointing a potential upside of 433.33%. HP has a concurrent price target of $26.71, specifying a potential upside of 30.55%. The consensus rating and higher probable upside of BIO-key International are stronger than HP’s, so equities analysts believe that BIO-key International is more commendatory than HP.

Comparing other factors of the two firms, HP beats BIO-key International on 8 of the 14 factors compared between the two stocks.

Comments

Popular posts from this blog

Digimarc and HP Collaborate on New Serialized  Package Printing Solution

USB Port on the HP OfficeJet 3830